Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Pharmacotherapy of Viral Disorders in Children

March 6, 2019 (Noon–1:15 p.m. ET)

Sponsor/Co-Sponsor(s)

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD

Purpose

David Kimberlin, M.D., will discuss the clinical pharmacology of infectious disease agents in children of all ages and the current approaches to pediatric drug development of these agents. During his presentation, Dr. Kimberlin will:

  • Describe clinical pharmacology principles of infectious disease agents.
  • List the drug development steps for infectious disease agents in children.

Dr. Kimberlin holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases at the University of Alabama at Birmingham, where he is co-director of the Division of Pediatric Infectious Diseases.

Contact

George Giacoia, OPPTB, NICHD
Phone: 301–496–5589
Email: giacoiag@mail.nih.gov

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of page BACK TO TOP